947248-50-2

Upstream product

• 1012343-75-7 2-(3-chloro-6-(tosylimino)pyridazin-1(6H)-yl)acetamide 
• 76-05-1 trifluoroacetic acid 
• 1244059-53-7 (Z)-2-(3-chloro-6-(tosylimino)pyridazin-1(6H)-yl)acetamide 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 1253409-03-8 C₂₃H₂₃N₇O₃ 
• 1191894-48-0 C₁₃H₁₂N₄O 
• 1192831-95-0 6-[3-(methylsulfonyl)phenyl]imidazo[1,2-b]pyridazin-2-amine 

Relevant academic research and scientific papers

AMINOIMIDAZOPYRIDINES AS KINASE INHIBITORS

Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.

IMIDAZO-FUSED HETEROCYCLES AND USES THEREOF

Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using imidazole-fused heterocycle amines. Some of the disclosed embodiments include imizazo-fused

MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE

The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase.

FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE

The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.

FUSED BICYCLIC COMPOUNDS AND USE THEREOF AS PI3K INHIBITORS

The invention relates to compounds of formula (I), for the regulation of phosphoinositides 3-kinases activity and related diseases.

Inhibitors of PI3 kinase

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.